FTC Sues Hims & Hers for Sending User Health Info to Meta, Snap

The U.S. Federal Trade Commission sued Hims & Hers on July 29 alleging the telehealth platform shared users’ health data with online advertisers, despite promising privacy, and engaged in deceptive billing and cancellation practices.
Users’ sensitive health information was shared with online advertising companies including Meta Platforms and Snap despite the company leading customers to believe their data was private, the FTC alleged in the lawsuit filed along with Los Angeles County and Utah.
Hims & Hers stock added to losses after the news and was trading down around 12%.
Hims & Hers is one of the largest telehealth players in the market for weight loss drugs. The company offers telehealth appointments and prescriptions for erectile dysfunction, hair loss, and mental health medications, which it ships straight to customers.
“The FTC will not hesitate to act on behalf of consumers deprived of their ability to choose which products they want and whether to keep their most sensitive health information private,” Christopher Mufarrige, Director of the FTC’s Bureau of Consumer Protection, said in a statement.
Hims & Hers called the claims baseless in a post on social media site X. “This is not enforcement grounded in consumer protection; it is an effort to generate headlines at our expense,” the company said in the post.
Hims & Hers also started charging users for prescriptions before they have had a chance to meet with healthcare providers, the FTC alleged.
Most customers do not receive a consultation with a provider, and instead are charged for prescriptions soon after filling out an intake form, according to the agency.
Hims & Hers also makes it difficult to cancel subscriptions, the FTC said.
Topics Lawsuits
Was this article valuable?
Here are more articles you may enjoy.

Facts Only

* The U.S. Federal Trade Commission sued Hims & Hers on July 29.
* The lawsuit alleged the telehealth platform shared user health data with online advertisers.
* The lawsuit claimed this sharing occurred despite promises of privacy.
* The lawsuit accused the company of deceptive billing and cancellation practices.
* Sensitive health information was allegedly shared with Meta Platforms and Snap.
* Hims & Hers is a large telehealth player for weight loss drugs, offering prescriptions for erectile dysfunction, hair loss, and mental health medications.
* The FTC alleged that customers were charged for prescriptions before they met with healthcare providers.
* The agency claimed most customers do not receive consultations but are charged for prescriptions after an intake form.
* The FTC asserted the company made it difficult to cancel subscriptions.

Executive Summary

The U.S. Federal Trade Commission sued Hims & Hers on July 29, alleging that the telehealth platform shared user health data with online advertisers while promising privacy. The lawsuit also accused the company of engaging in deceptive billing and cancellation practices. The FTC alleged that sensitive health information was shared with advertising companies including Meta Platforms and Snap, despite the company leading customers to believe their data remained private. Additionally, the agency asserted that Hims & Hers started charging users for prescriptions before they had an opportunity to consult with healthcare providers. Furthermore, the FTC stated that most customers do not receive provider consultations but are charged for prescriptions shortly after completing an intake form, and that the company made cancellation of subscriptions difficult. In response, Hims & Hers called the claims baseless on social media.

Full Take

The narrative centers on a conflict between corporate practice and consumer expectations regarding sensitive health data and transactional transparency in the digital health space. The pattern involves a discrepancy where stated commitments (privacy, consultation) are contrasted with operational realities (data sharing, immediate billing). This suggests a systemic challenge in how privacy and consent mechanisms function when platform business models rely on aggregated personal health information as a commodity for advertising revenue. The reaction from the company, framing the action as an attempt to generate headlines rather than consumer protection enforcement, reveals a strategic attempt to shift the focus from operational practices to reputational defense. The implication is that regulatory action is necessary to enforce meaningful consent over highly sensitive data and ensure transactional fairness in high-stakes services like telehealth. What mechanisms exist for consumers to effectively audit or regulate the promises made by digital platforms regarding data stewardship and service delivery timelines? How does the tension between rapid commercialization and established consumer protection frameworks reshape future regulation of personalized health technology?

Sentinel — Human

Confidence

This text reads like straightforward news reporting summarizing a legal action and the contested points, exhibiting characteristics of journalistic synthesis rather than generative pattern matching.

Signals Detected

Moderate sentence length variance; conversational tone shifts to formal legal language.

Clear focus on the core allegations and resulting actions, without unnecessary hedging or forced balance.

Direct citation of the lawsuit and specific allegations from the FTC; no vague attribution for key claims.

Factual reporting aligns with publicly known legal actions (FTC lawsuits); inclusion of a direct, contrasting quote feels contextually relevant to the event.

Human Indicators

The juxtaposition of a specific regulatory action (FTC lawsuit) with a direct corporate response (social media post) suggests engagement with real-time reporting and source material.

The flow transitions naturally between the allegation, the company's context, and the specific details of the claims.